Neurotech International Ltd (NTI) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.007x

Based on the latest financial reports, Neurotech International Ltd (NTI) has a cash flow conversion efficiency ratio of -0.007x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-38.33K ≈ $-27.12K USD) by net assets (AU$5.88 Million ≈ $4.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NTI defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Neurotech International Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Neurotech International Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Neurotech International Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neurotech International Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Quantum BioPharma Ltd. NASDAQ:QNTM	-0.229x
Golden Land Bhd KLSE:7382	-0.035x
Highway 50 Gold Corp V:HWY	-0.043x
Altamin Ltd AU:AZI	-0.491x
Inter-M Corporation KQ:017250	0.026x
Polyrizon Ltd. Ordinary Shares NASDAQ:PLRZ	-0.099x
Les Hôtels de Paris SA PA:HDP	1.495x
Peak Processing Limited AU:PKP	0.576x

Annual Cash Flow Conversion Efficiency for Neurotech International Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Neurotech International Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Neurotech International Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$2.95 Million ≈ $2.09 Million	AU$-9.02 Million ≈ $-6.39 Million	-3.054x	-690.85%
2024-06-30	AU$11.90 Million ≈ $8.42 Million	AU$-4.60 Million ≈ $-3.25 Million	-0.386x	+75.78%
2023-06-30	AU$3.96 Million ≈ $2.80 Million	AU$-6.32 Million ≈ $-4.47 Million	-1.594x	+22.85%
2022-06-30	AU$1.43 Million ≈ $1.01 Million	AU$-2.96 Million ≈ $-2.09 Million	-2.067x	-244.48%
2021-06-30	AU$3.86 Million ≈ $2.73 Million	AU$-2.32 Million ≈ $-1.64 Million	-0.600x	-156.78%
2020-06-30	AU$-646.29K ≈ $-457.29K	AU$-682.83K ≈ $-483.15K	1.057x	+112.36%
2019-06-30	AU$297.41K ≈ $210.44K	AU$-2.54 Million ≈ $-1.80 Million	-8.551x	-1095.71%
2018-06-30	AU$4.23 Million ≈ $2.99 Million	AU$-3.03 Million ≈ $-2.14 Million	-0.715x	+1.59%
2017-06-30	AU$4.30 Million ≈ $3.04 Million	AU$-3.12 Million ≈ $-2.21 Million	-0.727x	-1239.04%
2016-06-30	AU$14.48 Million ≈ $10.25 Million	AU$-785.79K ≈ $-555.99K	-0.054x	+91.75%
2015-12-31	AU$1.29 Million ≈ $916.07K	AU$-851.21K ≈ $-602.29K	-0.657x	--

About Neurotech International Ltd

AU:NTI Australia Biotechnology

Market Cap

$13.99 Million

AU$19.77 Million AUD

Market Cap Rank

#26190 Global

#1199 in Australia

Share Price

AU$0.02

Change (1 day)

-6.25%

52-Week Range

AU$0.01 - AU$0.03

All Time High

AU$0.48